About Acarbose
            
            Class: | Alpha-glucosidase inhibitor  
Use: | Management of type 2 diabetes mellitus, used to improve glycemic control in conjunction with diet and exercise  
Adult dose: | Initial dose: 25 mg orally three times a day with the first bite of each main meal; may be increased to 50 mg or 100 mg three times a day based on tolerance and glycemic control  
Pediatric dose: | Safety and efficacy not established in pediatric patients under 18 years; not recommended  
Side effects: | Gastrointestinal dist
         
        
            
                
                
                    
                        Drug Class
                    
                    Alpha-glucosidase inhibitor
                 
                
                
                    
                        Uses & Indications
                    
                    Management of type 2 diabetes mellitus, used to improve glycemic control in conjunction with diet and exercise
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20-25°C or 68-77°F) in a tightly closed container, protect from moisture
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Strides Pharma Inc., United States of America
                    
                    
                    Package Size
                    100's
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 106.40
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose: 25 mg orally three times a day with the first bite of each main meal; may be increased to 50 mg or 100 mg three times a day based on tolerance and glycemic control
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients under 18 years; not recommended
                    
                 
                
                
                    
                        Side Effects
                    
                    Gastrointestinal disturbances (flatulence, diarrhea, abdominal pain), hypoglycemia (when used with other antidiabetic agents), liver enzyme elevations
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to acarbose or any component of the formulation, inflammatory bowel disease, colonic ulceration, intestinal obstruction, severe renal impairment (creatinine clearance < 25 mL/min), pregnancy and lactation
         
        
        
            
                Important Warnings
            
            Risk of hypoglycemia when used with other antidiabetic medications; gastrointestinal side effects may be severe; monitor liver function tests periodically; not for use in patients with significant renal impairment or gastrointestinal disorders
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.